Physician profile
Luis A Jovel
NPI 1073560124
$5,851.24
in general payments reported to CMS, 2019-2025
20 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,734 · 2020: $521 · 2021: $596 · 2022: $1,089 · 2023: $1,068 · 2024: $504 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,911.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,366.81 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $1,088.44 | 2019-2022 | |
| Lilly USA, LLC | $950.36 | 2019-2025 | Mounjaro, Trulicity, Kisunla |
| Astrazeneca Pharmaceuticals LP | $772.01 | 2019-2025 | Farxiga, Airsupra |
| Pfizer INC. | $463.32 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $272.31 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.78 | 2019-2025 | Jardiance |
| Biohaven Pharmaceuticals, INC. | $143.15 | 2021 | |
| Abbvie INC. | $90.40 | 2022-2024 | |
| Dexcom, INC. | $90.00 | 2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $80.47 | 2019-2020 | |
| Exact Sciences Corporation | $76.36 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $73.77 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $46.46 | 2019-2020 | |
| Astellas Pharma US INC | $23.94 | 2023 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $22.44 | 2023 | |
| Sanofi-Aventis U.S. LLC | $20.11 | 2019 | |
| Horizon Therapeutics Plc | $19.16 | 2023 | Krystexxa |
| Abbott Laboratories | $16.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Jovel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.